The relationship of CASP 8 polymorphism and cancer susceptibility: A meta-analysis

Cellular and Molecular Biology

Volumn 60, Issue 6, 2014, Pages 20-28

  Ji, G H ^a,b   Li, M ^c   Cui, Y ^d   Wang, Jiufei ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c DAQING OILFIELD GENERAL HOSPITAL   (China)

^d Harbin Blood Center   (China)

Author keywords

Cancer; CASP8; Meta analysis; Polymorphism

Indexed keywords

CASPASE 8; CASP8 PROTEIN, HUMAN;

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; DIGESTIVE SYSTEM CANCER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MULTIPLE CANCER; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; RISK FACTOR;

CASPASE 8; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84941098358     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2014.60.6.4     Document Type: Article

References (51)

1. Harada H. and Grant S.: Apoptosis regulators. Rev. Clin. Exp. Hematol. 2003, 7: 117-138.
2. Pradelli L.A., Beneteau M. and Ricci J.E.: Mitochondrial control of caspase-dependent and -independent cell death. Cell. Mol. Life. Sci. 2007, 67: 1589-1597.
3. Fuchs Y. and Steller H.: Programmed cell death in animal development and disease. Cell. 2011, 147: 742-758.
4. Green D. and Kroemer G.: The central executioners of apoptosis:caspases or mitochondria? Trends. Cell. Biol. 1998, 8: 267-271.
5. Crowder R.N. and El-Deiry W.S.: Caspase-8 regulation of trail-mediated cell death. Exp. Oncol. 2012, 34: 160-164.
6. Fulda S: Caspase-8 in cancer biology and therapy. Cancer. Lett. 2009, 281: 128-133.
7. MacPherson G., Healey C.S., Teare M.D., et al: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl. Cancer. Inst. 2004, 96: 1866-1869.
8. Sun T., Gao Y., Tan W., et al: A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat. Genet. 2007, 39: 605-613.
9. Shephard N.D., Abo R., Rigas S.H., et al: A breast cancer risk haplotype in the caspase-8 gene. Cancer. Res. 2009, 69: 2724-2728.
10. Cox A., Dunning A.M., Garcia-Closas M., et al: A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 2007, 39: 352-358.
11. Hashemi M., Eskandari-Nasab E., Fazaeli A., et al: Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 2012, 505: 176-179.
12. Haiman C.A., Garcia R.R., Kolonel L.N., Henderson B.E., Wu A.H. and Le Marchand L.: A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat. Genet. 2008, 40: 259-260.
13. Cybulski C., Wokolorczyk D., Gliniewicz B., et al: A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast. Cancer. Res. Treat. 2008, 112: 367-368.
14. Xiao M.S., Chang L., Li W.L., et al: Genetic polymorphisms of the CASP8 gene promoter may not be associated with colorectal cancer in Han Chinese from southwest China. PLoS. One. 2013, 8: e67577.
15. Sergentanis T.N. and Economopoulos K.P.: Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Breast. Cancer. Res. Treat. 2010, 120: 229-234.
16. Yin M., Yan J., Wei S. and Wei Q.: CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis. 2010, 31: 850-857.
17. Zhang F., Yang Y., Guo C. and Wang Y.: CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects. Mutagenesis. 2012, 27: 559-566.
18. De Vecchi G., Verderio P., Pizzamiglio S., et al: Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases. Breast. Cancer. Res. Treat. 2009, 113: 607-608.
19. Umar M., Upadhyay R., Kumar S., Ghoshal U.C. and Mittal B.: CASP8 -652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/prognosis of ESCC: a case control study in northern Indian population. J. Surg. Oncol. 2011, 103: 716-723.
20. George G.P. and Mittal R.D.: Caspase 8 gene variants in healthy North Indian population and comparison with worldwide ethnic group variations. Indian. J. Hum. Genet. 2011, 16: 144-148.
21. Kesarwani P., Mandal R.K., Maheshwari R. and Mittal R.D.: Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU. Int. 2010, 107: 471-476.
22. Chatterjee K., Williamson A.L., Hoffman M. and Dandara C.: CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer. J. Med. Virol. 2011, 83: 630-636.
23. Ma X., Zhang J., Liu S., Huang Y., Chen B. and Wang D.: Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer. Gynecol. Oncol. 2011, 122: 554-559.
24. Li C., Lu J., Liu Z., et al: The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer. Prev. Res. (Phila) 2010, 3: 246-253,.
25. Wu Z., Li Y., Li S., et al: Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer. Med. Oncol. 2013, 30: 565.
26. Sergentanis T.N. and Economopoulos K.P.: Validating the meta-analytical results on MDM2, CASP8, XRCC3 polymorphisms and breast cancer risk: examination of Hardy-Weinberg Equilibrium. Breast. Cancer. Res. Treat. 2011, 126: 819-823.
27. Lee S.Y., Choi Y.Y., Choi J.E., et al: Polymorphisms in the caspase genes and the risk of lung cancer. J. Thorac. Oncol. 2010, 5: 1152-1158.
28. Hart K., Landvik N.E., Lind H., Skaug V., Haugen A. and Zienolddiny S.: A combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancer. Lung. Cancer. 2010, 71: 123-129.
29. Rajaraman P., Wang S.S., Rothman N., et al: Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer. Epidemiol. Biomarkers. Prev. 2007, 16: 1655-1661.
30. Son J.W., Kang H.K., Chae M.H., et al: Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer. Genet. Cytogenet. 2006, 169: 121-127.
31. Liu B., Zhang Y., Jin M., et al: Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol. Carcinog. 2010, 49: 75-84.
32. Pittman A.M., Broderick P., Sullivan K., et al: CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br. J. Cancer. 2008, 98: 1434-1436.
33. Theodoropoulos G.E., Gazouli M., Vaiopoulou A., et al: Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int. J. Colorectal. Dis. 2011, 26: 1113-1118.
34. Liamarkopoulos E., Gazouli M., Aravantinos G., et al: Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric. Cancer. 2011, 14: 317-321.
35. Yang M., Sun T., Wang L., et al: Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin. Cancer. Res. 2008, 14: 3230-3236.
36. Srivastava K., Srivastava A. and Mittal B.: Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population. Mol. Carcinog. 2010, 49: 684-692.
37. George G.P. and Mittal R.D.: Caspase 8 gene variants in healthy North Indian population and comparison with worldwide ethnic group variations. Indian. J. Hum. Genet. 2010, 16: 144-148.
38. Kesarwani P., Mandal R.K., Maheshwari R. and Mittal R.D.: Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU. Int. 2011, 107: 471-476.
39. Gangwar R., Mandhani A. and Mittal R.D.: Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann. Surg. Oncol. 2009, 16: 2028-2034.
40. Wang S.S., Ye Y., Qian H.Y., Song Z.F., Jia X.M. and Ni C.H.: [Polymorphisms in Fas pathway genes and risk of coal worker pneumoconiosis]. Zhong. hua. Lao. Dong. Wei. Sheng. Zhi. Ye. Bing. Za. Zhi. 2012, 29: 756-760.
41. Xiao M.S., Zhang D.F., Zeng Y., Cheng Y.F. and Yao Y.G.:Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients. Ann. Hematol. 2011, 90: 1137-1144.
42. Lv Z.: Genetic polymorphism in CASP8, Fas and Fas ligand and the risk of peripheral T-cell lymphoma and the relationship between the genetic polymorphisms and the clinical characteristics and prognosis. Thesis. of. Peking. Union. Medical. University. 2010.
43. Li C., Zhao H., Hu Z., et al: Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum. Mutat. 2008, 29: 1443-1451.
44. Wang Y.X., Zhao L., Wang X.Y., Liu C.M. and Yu S.G.: Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population. Med. Oncol. 2012, 29: 2445-2451.
45. Zhu J., Qin C., Wang M., et al: Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma. Mol. Carcinog. 2010, 49: 810-817.
46. Frank B., Hemminki K., Wappenschmidt B., et al: Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis. 2006, 27: 606-609.
47. Sigurdson A.J., Bhatti P., Doody M.M., et al: Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists. Cancer. Epidemiol. Biomarkers. Prev. 2007, 16: 2000-2007.
48. Ramus S.J., Vierkant R.A., Johnatty S.E., et al: Consortium analysis of 7 candidate SNPs for ovarian cancer. Int. J. Cancer. 2008, 123: 380-388.
49. Bethke L., Sullivan K., Webb E., et al: CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer. Lett. 2009, 273: 312-315.
50. Enjuanes A., Benavente Y., Bosch F., et al: Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer. Res. 2008, 68: 10178-10186.
51. Lan Q., Zheng T., Chanock S., et al: Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis. 2007, 28: 823-827.